Biogen Inc (BIIB)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	4,545,100	4,293,100	5,114,100	5,316,400	11,639,400
Revenue	US$ in thousands	9,675,900	9,835,600	10,173,400	10,981,700	13,444,600
Gross profit margin		46.97%	43.65%	50.27%	48.41%	86.57%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $4,545,100K ÷ $9,675,900K
= 46.97%

Biogen Inc's gross profit margin has shown fluctuations over the years as follows:

- As of December 31, 2020, the gross profit margin was strong at 86.57%, indicating that the company was able to efficiently generate revenue after accounting for the cost of goods sold.
- By December 31, 2021, the gross profit margin dropped to 48.41%, suggesting a significant decrease in the profitability of Biogen Inc's core operations.
- The gross profit margin improved slightly to 50.27% by December 31, 2022, indicating a partial recovery in the company's ability to generate profits.
- However, as of December 31, 2023, the gross profit margin declined to 43.65%, signaling a decrease in efficiency in generating profits relative to the revenue earned.
- By December 31, 2024, the gross profit margin saw a slight increase to 46.97%, but it remained below the levels seen in 2020.

Overall, the trend in Biogen Inc's gross profit margin reflects fluctuations in the company's ability to manage its production costs and pricing strategies effectively, impacting its overall profitability over the specified period.